Last reviewed · How we verify

NCT04686435

Metabolic Syndrome and Persistent Shoulder Pain 1 Year After Primary Diagnosis

Completed Last updated 18 September 2025
What this trial tests

trial testing Non-surgical treatment such as physiotherapy, exercise, corticosteroid injection, medication, acupuncture in Shoulder Pain in 1,100 participants. Completed in 4 January 2025.

Timeline
4 January 2021
Primary endpoint
4 January 2025
4 January 2025

Quick facts

Lead sponsorVejle Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,100
Start date4 January 2021
Primary completion4 January 2025
Estimated completion4 January 2025
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Vejle Hospital

Who can join

Adults 18 to 75, any sex, with Shoulder Pain or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In a longitudinal cohort project, the objective is to evaluate general prognostic and individual risk factors for long lasting shoulder pain, with a specific focus on evaluation of the association between metabolic syndrome and tendinopathy, while simultaneous adjusting for other potential prognostic candidate variables (PROGRESS Theme I-II).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

Other Vejle Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04686435.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing